These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Apolipoprotein E polymorphism and plasma lipid, lipoprotein, apolipoprotein levels in 291 children of Changsha]. Xiang W; Zhao S; Peng D Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):232-6. PubMed ID: 12016791 [TBL] [Abstract][Full Text] [Related]
24. Coronary artery disease, lipid disorders and genetic polymorphisms. Ordovas JM; Schaefer EJ Ann Biol Clin (Paris); 1988; 46(1):24-9. PubMed ID: 2898907 [TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coronary artery disease. Puri RD; Tewari S; Sinha N; Ramesh V; Khan F; Singh VP; Agrawal S Indian Heart J; 2003; 55(1):60-4. PubMed ID: 12760590 [TBL] [Abstract][Full Text] [Related]
26. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Xu CF; Angelico F; Del Ben M; Humphries S Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925 [TBL] [Abstract][Full Text] [Related]
27. Influence of apolipoproteins on the anatomical distribution of arterial disease. Wiseman SA; Powell JT; Barber N; Humphries SE; Greenhalgh RM Atherosclerosis; 1991 Aug; 89(2-3):231-7. PubMed ID: 1686549 [TBL] [Abstract][Full Text] [Related]
28. Genetic studies of human apolipoproteins. XVIII. Apolipoprotein polymorphisms in Australian Aborigines. Kamboh MI; Serjeantson SW; Ferrell RE Hum Biol; 1991 Apr; 63(2):179-86. PubMed ID: 2019410 [TBL] [Abstract][Full Text] [Related]
29. [Progress in the study of lipoprotein metabolism and atherosclerosis: progress in the molecular genetic study of apolipoproteins and hyperlipidemia]. Itoh H; Mabuchi H; Takeda R Nihon Rinsho; 1988 Mar; 46(3):644-51. PubMed ID: 2900342 [No Abstract] [Full Text] [Related]
33. Candidate genes, small effects, and the prediction of atherosclerosis. Hegele RA Crit Rev Clin Lab Sci; 1997; 34(4):343-67. PubMed ID: 9288444 [TBL] [Abstract][Full Text] [Related]
34. DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Humphries SE Atherosclerosis; 1988 Aug; 72(2-3):89-108. PubMed ID: 3063270 [TBL] [Abstract][Full Text] [Related]
35. Genetic architecture of inter-individual variability in apolipoprotein, lipoprotein and lipid phenotypes. Sing CF; Boerwinkle EA Ciba Found Symp; 1987; 130():99-127. PubMed ID: 3327665 [TBL] [Abstract][Full Text] [Related]
36. [Epidemiology and molecular genetics of atherosclerosis]. Cambien F Journ Annu Diabetol Hotel Dieu; 1991; ():19-24. PubMed ID: 1679467 [No Abstract] [Full Text] [Related]
37. [Restriction fragment length polymorphisms in apolipoprotein genes in diabetes mellitus]. Itoh H; Kajinami K; Mabuchi H; Takeda R Nihon Rinsho; 1991 Feb; 49 Suppl():542-7. PubMed ID: 1674555 [No Abstract] [Full Text] [Related]
38. Genetics of coronary heart disease and its risk factors. Berg K Ciba Found Symp; 1987; 130():14-33. PubMed ID: 2964999 [TBL] [Abstract][Full Text] [Related]
39. The genetics of atherosclerosis. Galton DJ Proc Nutr Soc; 1987 Sep; 46(3):337-43. PubMed ID: 3124116 [No Abstract] [Full Text] [Related]
40. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia. Choluj B; Votruba T Acta Univ Carol Med (Praha); 1991; 37(3-4):129-40. PubMed ID: 1845467 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]